AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CYCLOPHARM LTD

0.850

+0.0303.66%

Volume:27.00K

Turnover:22.35K

Market Cap:102.52M

PE:-5.43

High:0.850

Open:0.830

Low:0.820

Close:0.820

52wk High:1.475

52wk Low:0.560

Shares:120.61M

Float Shares:56.55M

Volume Ratio:0.60

T/O Rate:0.05%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.156

EPS(LYR):-0.156

ROE:-49.31%

ROA:-20.29%

PB:3.78

PE(LYR):-5.43

Loading ...

Overview Company News Filings

BUZZ-Australia's Cyclopharm drops to one-week low on discounted placement

Cyclopharm Ltd - Spp to Raise up to a$2 Mln at a$0.95 per Share

THOMSON REUTERS

BRIEF-Cyclopharm Logs FY Unaudited Operating Revenue A$32.3 Mln

Cyclopharm Ltd - FY Unaudited Operating Revenue a$32.3 Mln

THOMSON REUTERS

BRIEF-Cyclopharm Seeks Trading Halt

Cyclopharm Enters Research Collaboration With Macquarie University To Evaluate Treatment For Chronic Obstructive Pulmonary Disease

MT Newswires Live

Cyclopharm's Lung Imaging Product Recognized as Preferred Agent in Draft Clinical Guideline; Shares Up 13%

MT Newswires Live

Cyclopharm Says Insurer Assumes Conduct of Defense Against 4DMedical Lawsuit In Victoria Supreme Court, Shares Jump 11%

MT Newswires Live

BRIEF-Cyclopharm Confirms Insurer Accepted Indemnity In Respect Of Proceedings

BUZZ-Australia's Cyclopharm rises on med-tech clinical guideline win in US

Cyclopharm Ltd - Confirms That Its Insurer Has Accepted Indemnity in Respect of Proceedings

THOMSON REUTERS

Cyclopharm Ltd - Refers to Lodgement of Legal Proceedings by 4DMedical Against Cyclopharm

THOMSON REUTERS

Cyclopharm Agrees to Implement Lung Imaging Technology at US-Based Children's Hospital

MT Newswires Live

Cyclopharm Limited's (ASX:CYC) Price Is Right But Growth Is Lacking After Shares Rocket 28%

Simply Wall St.

Cyclopharm Says Technegas Technology Approved in Colombia; Shares Up 5%

MT Newswires Live

Cyclopharm Partners With Western University to Test Technegas in Mild Asthma

MT Newswires Live

Cyclopharm Finalizes Sale of Cyclotron Asset

MT Newswires Live

Cyclopharm Ltd-Cyclopharm Completes Sale of Cyclotron Asset

THOMSON REUTERS

Benign Growth For Cyclopharm Limited (ASX:CYC) Underpins Stock's 29% Plummet

Simply Wall St.

Shares of Cyclopharm Fall on Legal Action by 4DMedical

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CYC.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CYC.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CYC.AU\",,,,,undefined,":{"symbol":"CYC.AU","market":"AU","secType":"STK","nameCN":"CYCLOPHARM LTD","latestPrice":0.85,"timestamp":1775106720000,"preClose":0.82,"halted":0,"volume":27002,"delay":0,"changeRate":0.03658536585365857,"nameEN":"CYCLOPHARM LTD","floatShares":56552486,"shares":120610534,"eps":-0.1564,"marketStatus":"Market Closed","change":0.03,"latestTime":"04-02 16:12:00 AEDT","open":0.83,"high":0.85,"low":0.82,"amount":22348,"amplitude":0.036585,"askPrice":0.865,"askSize":5000,"bidPrice":0.815,"bidSize":9929,"shortable":3,"etf":0,"ttmEps":-0.1564,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1775520000000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.82,"openAndCloseTimeList":[[1775084400000,1775106000000]],"volumeRatio":0.5998178476572279,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CYC.AU","preClose":0.82,"auctionPrice":0.85,"auctionVolume":1,"auction":3,"marketStatus":"盘后竞价","timestamp":1775106592166}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CYC.AU\",,,,,undefined,":{"symbol":"CYC.AU","floatShares":56552486,"roa":"-20.29%","roe":"-49.31%","lyrEps":-0.1564,"volumeRatio":0.5998178476572279,"shares":120610534,"dividePrice":0,"high":0.85,"amplitude":0.036585,"preClose":0.82,"low":0.82,"week52Low":0.56,"pbRate":"3.78","psRate":"3.17","week52High":1.475,"institutionHeld":0,"latestPrice":0.85,"committee":0.330163,"eps":-0.1564,"divideRate":0,"volume":27002,"delay":0,"ttmEps":-0.1564,"open":0.83,"prevYearClose":0.98,"prevWeekClose":0.75,"prevMonthClose":0.85,"prevQuarterClose":0.85,"fiveDayClose":0.74,"twentyDayClose":0.74,"sixtyDayClose":0.99,"dividendGrowthYears":4,"dividendGrowthRate":0,"fiveYearAvgDividendRate":0.006534753846142799},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CYC.AU\",params:#limit:5,,,undefined,":[{"date":"2023-09-01","symbol":"CYC.AU","amount":0.005,"announcedDate":"2023-08-22","type":"dividend","market":"AU","newRecordDate":"2023-09-04","defaultRemindTime":1693526400000,"name":"Cyclopharm Ltd","recordDate":"2023-09-11","payableDate":"2023-09-04","currency":"AUD","dateTimestamp":1693490400000,"payDate":"2023-09-11"},{"market":"AU","date":"2023-03-27","symbol":"CYC.AU","amount":0.005,"defaultRemindTime":1679871600000,"name":"Cyclopharm Ltd","recordDate":"2023-04-04","payableDate":"2023-03-28","currency":"AUD","type":"dividend","dateTimestamp":1679835600000},{"market":"AU","date":"2022-09-02","symbol":"CYC.AU","amount":0.005,"defaultRemindTime":1662076800000,"name":"Cyclopharm Ltd","recordDate":"2022-09-12","payableDate":"2022-09-05","currency":"AUD","type":"dividend","dateTimestamp":1662040800000},{"market":"AU","date":"2022-04-04","symbol":"CYC.AU","amount":0.005,"defaultRemindTime":1649030400000,"name":"Cyclopharm Ltd","recordDate":"2022-04-12","payableDate":"2022-04-05","currency":"AUD","type":"dividend","dateTimestamp":1648994400000},{"market":"AU","date":"2021-09-03","symbol":"CYC.AU","amount":0.005,"defaultRemindTime":1630627200000,"name":"Cyclopharm Ltd","recordDate":"2021-09-13","payableDate":"2021-09-06","currency":"AUD","type":"dividend","dateTimestamp":1630591200000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CYC.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-04","recordDate":"2020-09-07","paymentDate":"2020-09-14","value":0.005,"currency":"AUD"},{"executeDate":"2021-04-01","recordDate":"2021-04-06","paymentDate":"2021-04-13","value":0.005,"currency":"AUD"},{"executeDate":"2021-09-03","recordDate":"2021-09-06","paymentDate":"2021-09-13","value":0.005,"currency":"AUD"},{"executeDate":"2022-04-04","recordDate":"2022-04-05","paymentDate":"2022-04-12","value":0.005,"currency":"AUD"},{"executeDate":"2022-09-02","recordDate":"2022-09-05","paymentDate":"2022-09-12","value":0.005,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CYC.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2608873823","title":"BUZZ-Australia's Cyclopharm drops to one-week low on discounted placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2608873823","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608873823?lang=en_us&edition=fundamental","pubTime":"2026-02-04 09:09","pubTimestamp":1770167341,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Cyclopharm drops to one-week low on discounted placement** Shares of Cyclopharm CYC.AX fall as much as 19.7% to A$0.94, their lowest level since January 27** The radiopharmaceutical c","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nL4N3Z003D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","CYC.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608261386","title":"Cyclopharm Ltd - Spp to Raise up to a$2 Mln at a$0.95 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2608261386","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608261386?lang=en_us&edition=fundamental","pubTime":"2026-02-04 06:40","pubTimestamp":1770158437,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nFWN3YZ14P:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","CYC.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608588073","title":"BRIEF-Cyclopharm Logs FY Unaudited Operating Revenue A$32.3 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2608588073","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608588073?lang=en_us&edition=fundamental","pubTime":"2026-02-02 09:04","pubTimestamp":1769994293,"startTime":"0","endTime":"0","summary":"BRIEF-Cyclopharm Logs FY Unaudited Operating Revenue A$32.3 MlnFeb 2 (Reuters) - Cyclopharm Ltd CYC.AX:FY UNAUDITED OPERATING REVENUE A$32.3 MILLIONFurther company coverage: CYC.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nFWN3YX05T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","CYC.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608002884","title":"Cyclopharm Ltd - FY Unaudited Operating Revenue a$32.3 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2608002884","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608002884?lang=en_us&edition=fundamental","pubTime":"2026-02-02 06:40","pubTimestamp":1769985632,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260201:nFWN3YX05T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CYC.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608884498","title":"BRIEF-Cyclopharm Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2608884498","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608884498?lang=en_us&edition=fundamental","pubTime":"2026-02-02 06:13","pubTimestamp":1769984020,"startTime":"0","endTime":"0","summary":"BRIEF-Cyclopharm Seeks Trading HaltFeb 2 (Reuters) - Cyclopharm Ltd CYC.AX:REQUESTS TRADING HALT FOR CAPITAL RAISINGFurther company coverage: CYC.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260201:nFWN3YX05N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","CYC.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607656772","title":"Cyclopharm Enters Research Collaboration With Macquarie University To Evaluate Treatment For Chronic Obstructive Pulmonary Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2607656772","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607656772?lang=en_us&edition=fundamental","pubTime":"2026-01-29 13:29","pubTimestamp":1769664563,"startTime":"0","endTime":"0","summary":"Cyclopharm  entered a clinical research collaboration with Macquarie University and Macquarie University Hospital to evaluate a new treatment approach for patients with severe chronic obstructive pulmonary disease, the Endoscopic Segmental Sealant Ablation  study, according to a Thursday Australian bourse filing.The ESSA procedure is a minimally invasive bronchoscopic treatment targeting damaged parts of the lung at a smaller, segment-by-segment level, seeking to induce segmental lung volume reduction with the instillation of polymer foam.The study will use artificial intelligence-based lung imaging technology from Thirona, applied to nuclear medicine ventilation-perfusion (V/Q) single-photon emission computed tomography-computed tomography scans generated using Technegas.The study will recruit 34 patients with severe or very severe chronic obstructive pulmonary disease.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4195","BK7007","CYC.AU","BK4211","BK7511","MQG.AU","ESSA","BK7046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606276575","title":"Cyclopharm's Lung Imaging Product Recognized as Preferred Agent in Draft Clinical Guideline; Shares Up 13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606276575","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606276575?lang=en_us&edition=fundamental","pubTime":"2026-01-27 10:25","pubTimestamp":1769480725,"startTime":"0","endTime":"0","summary":"Cyclopharm  said its Technegas lung imaging product was recognized as a preferred ventilation agent in a new draft clinical guideline for lung imaging, according to a Tuesday filing with the Australian bourse.The Procedure Standard and Guideline for Ventilation-Perfusion Pulmonary Scintigraphy recognized Technegas for clinical use in the US, designating it as a preferred ventilation agent when available, the filing said.The draft guideline has been released for public consultation and will be refined for factual variations, per the filing.Shares rose 13% in afternoon trade on Tuesday.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CYC.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606275051","title":"Cyclopharm Says Insurer Assumes Conduct of Defense Against 4DMedical Lawsuit In Victoria Supreme Court, Shares Jump 11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606275051","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606275051?lang=en_us&edition=fundamental","pubTime":"2026-01-27 10:15","pubTimestamp":1769480153,"startTime":"0","endTime":"0","summary":"Cyclopharm  confirmed that its insurer accepted indemnity regarding proceedings brought by 4DMedical  in the Supreme Court of Victoria against the firm and the insurer assumed conduct of the defense on Cyclopharm's behalf, according to a Tuesday Australian bourse filing.4DMedical sued the firm over allegedly misleading comments made during a March webinar, claiming the comment about its capital raising statements was false and misleading, and alleging that it caused damage to the company.Its shares jumped 11% in recent trading on Tuesday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CYC.AU","BK4095","4DX.AU","VCCTF","BK7094","BK7007"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2606782422","title":"BRIEF-Cyclopharm Confirms Insurer Accepted Indemnity In Respect Of Proceedings","url":"https://stock-news.laohu8.com/highlight/detail?id=2606782422","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606782422?lang=en_us&edition=fundamental","pubTime":"2026-01-27 09:18","pubTimestamp":1769476693,"startTime":"0","endTime":"0","summary":"BRIEF-Cyclopharm Confirms Insurer Accepted Indemnity In Respect Of ProceedingsJan 27  - Cyclopharm Ltd CYC.AX:CONFIRMS THAT ITS INSURER HAS ACCEPTED INDEMNITY IN RESPECT OF PROCEEDINGSREFERS TO LODGEMENT OF LEGAL PROCEEDINGS BY 4DMEDICAL AGAINST CYCLOPHARMFurther company coverage: CYC.AX ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nFWN3YR0QE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CYC.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606426278","title":"BUZZ-Australia's Cyclopharm rises on med-tech clinical guideline win in US","url":"https://stock-news.laohu8.com/highlight/detail?id=2606426278","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606426278?lang=en_us&edition=fundamental","pubTime":"2026-01-27 09:14","pubTimestamp":1769476465,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Cyclopharm rises on med-tech clinical guideline win in US** Shares of Cyclopharm CYC.AX advance as much as 15.34% to A$1.015, their biggest intraday pct gain December 1, 2025** The ra","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nL6N3YS02L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","4DX.AU","BK7094","CYC.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606226770","title":"Cyclopharm Ltd - Confirms That Its Insurer Has Accepted Indemnity in Respect of Proceedings","url":"https://stock-news.laohu8.com/highlight/detail?id=2606226770","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606226770?lang=en_us&edition=fundamental","pubTime":"2026-01-27 05:27","pubTimestamp":1769462878,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nFWN3YR0QE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","CYC.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606226085","title":"Cyclopharm Ltd -  Refers to Lodgement of Legal Proceedings by 4DMedical Against Cyclopharm","url":"https://stock-news.laohu8.com/highlight/detail?id=2606226085","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606226085?lang=en_us&edition=fundamental","pubTime":"2026-01-27 05:27","pubTimestamp":1769462878,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nFWN3YR0QE:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","CYC.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602593751","title":"Cyclopharm Agrees to Implement Lung Imaging Technology at US-Based Children's Hospital","url":"https://stock-news.laohu8.com/highlight/detail?id=2602593751","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602593751?lang=en_us&edition=fundamental","pubTime":"2026-01-12 13:52","pubTimestamp":1768197177,"startTime":"0","endTime":"0","summary":"Cyclopharm (ASX:CYC) agreed to implement its diagnostic lung imaging technology Technegas at Lucile Packard Children's Hospital Stanford in the US, according to a Monday filing with the Australian bourse.Shares of the company rose 6% at market close.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CYC.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593447766","title":"Cyclopharm Limited's (ASX:CYC) Price Is Right But Growth Is Lacking After Shares Rocket 28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593447766","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593447766?lang=en_us&edition=fundamental","pubTime":"2025-12-24 04:02","pubTimestamp":1766520164,"startTime":"0","endTime":"0","summary":"Cyclopharm Limited ( ASX:CYC ) shares have had a really impressive month, gaining 28% after a shaky period beforehand...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-cyc/cyclopharm-shares/news/cyclopharm-limiteds-asxcyc-price-is-right-but-growth-is-lack","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-cyc/cyclopharm-shares/news/cyclopharm-limiteds-asxcyc-price-is-right-but-growth-is-lack","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7007","CYC.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593702061","title":"Cyclopharm Says Technegas Technology Approved in Colombia; Shares Up 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593702061","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593702061?lang=en_us&edition=fundamental","pubTime":"2025-12-22 11:05","pubTimestamp":1766372732,"startTime":"0","endTime":"0","summary":"Cyclopharm (ASX:CYC) said its Technegas technology, which provides high-resolution ventilation imaging at the site where oxygen is taken up in the lung, received regulatory approval in Colombia, accor","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CYC.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2585637971","title":"Cyclopharm Partners With Western University to Test Technegas in Mild Asthma","url":"https://stock-news.laohu8.com/highlight/detail?id=2585637971","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585637971?lang=en_us&edition=fundamental","pubTime":"2025-11-21 06:37","pubTimestamp":1763678272,"startTime":"0","endTime":"0","summary":"Cyclopharm  launched a 12-month clinical trial with Western University in Canada to investigate whether its Technegas technology can reveal hidden lung airflow issues in young adults with mild asthma, according to a Friday filing with the Australian bourse.The clinical trial will enroll 40 participants aged 17 to 35 with mild asthma to investigate hidden lung airflow issues that may not be detectable through symptoms alone, the filing added.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4168","CYC.AU","BK7007","WRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2582526348","title":"Cyclopharm Finalizes Sale of Cyclotron Asset","url":"https://stock-news.laohu8.com/highlight/detail?id=2582526348","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582526348?lang=en_us&edition=fundamental","pubTime":"2025-11-12 11:20","pubTimestamp":1762917657,"startTime":"0","endTime":"0","summary":"Cyclopharm (ASX:CYC) completed the sale of its Cyclotron asset, receiving a total of AU$6.2 million, according to a Wednesday filing with the Australian bourse.Shares rose nearly 2% in afternoon trade on Wednesday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CYC.AU","BK7007","XJO.AU","XKO.AU","XAO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2582312480","title":"Cyclopharm Ltd-Cyclopharm Completes Sale of Cyclotron Asset","url":"https://stock-news.laohu8.com/highlight/detail?id=2582312480","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582312480?lang=en_us&edition=fundamental","pubTime":"2025-11-12 09:56","pubTimestamp":1762912575,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nTUE17FZPP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CYC.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2575387237","title":"Benign Growth For Cyclopharm Limited (ASX:CYC) Underpins Stock's 29% Plummet","url":"https://stock-news.laohu8.com/highlight/detail?id=2575387237","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575387237?lang=en_us&edition=fundamental","pubTime":"2025-10-14 04:04","pubTimestamp":1760385861,"startTime":"0","endTime":"0","summary":"Unfortunately for some shareholders, the Cyclopharm Limited ( ASX:CYC ) share price has dived 29% in the last thirty...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-cyc/cyclopharm-shares/news/benign-growth-for-cyclopharm-limited-asxcyc-underpins-stocks","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-cyc/cyclopharm-shares/news/benign-growth-for-cyclopharm-limited-asxcyc-underpins-stocks","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CYC.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2573588915","title":"Shares of Cyclopharm Fall on Legal Action by 4DMedical","url":"https://stock-news.laohu8.com/highlight/detail?id=2573588915","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573588915?lang=en_us&edition=fundamental","pubTime":"2025-10-08 10:34","pubTimestamp":1759890845,"startTime":"0","endTime":"0","summary":"Shares of Cyclopharm  fell over 6% in recent Wednesday trade after it said in a late Tuesday filing that it had been served with legal proceedings by 4DMedical  over allegedly misleading comments made during a March webinar.4DMedical claims the comment about its capital raising statements was false and misleading, and alleges it caused damage to the company, per the filing.Cyclopharm rejected the allegations, stating it considers the claim to be without merit, the filing said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7094","BK7007","CYC.AU","4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":43,"code":"91000000","status":"200"}]}}